GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EUZacks Investment Research • 12/15/25
GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital GonorrheaZacks Investment Research • 12/12/25
GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung CancerZacks Investment Research • 12/11/25
GSK Stock Up Almost 19% in 3 Months: Should You Buy, Hold or Sell?Zacks Investment Research • 12/11/25
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of CancerGlobeNewsWire • 12/10/25
Leading bank tips AstraZeneca as 2026's standout UK pharma, with GSK left trailingProactive Investors • 12/08/25
Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newbornsReuters • 12/05/25
AnaptysBio Buckles After Trading Legal Barbs With Pharma Giant GSKInvestors Business Daily • 11/21/25
GSK plc (GSK) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/19/25
GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growthReuters • 11/06/25